Key result
Discordantly high remnant cholesterol linked to ~26% higher MASLD risk than discordantly high LDL-C.
Why the study?
Is high remnant cholesterol discordant with LDL-C associated with increased risk of MASLD in patients with T2DM?
Cross-Sectional (n=26,302)
Is high remnant cholesterol discordant with LDL-C associated with increased risk of MASLD in patients with T2DM?
Answers are grounded in this paper and cite their sources.
In patients with T2DM, discordantly high remnant cholesterol is more strongly associated with the risk of MASLD than LDL-C, suggesting RC as a potential therapeutic target.
Introduction Type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD) frequently coexist in the same individual. Dyslipidemia plays a central role in the pathogenesis of MASLD. Remnant cholesterol (RC) is the cholesterol content carried in triglyceride-rich lipoproteins. We aimed to examine the association of RC, its discordance with low-density lipoprotein cholesterol (LDL-C) in terms of MASLD risk in patients with T2DM. Research design and methods A total of 26 302 T2DM patients who were hospitalized were cross-sectionally assessed. Logistic regression models were employed to assess the associations. We used three approaches to assess the effects of the discordance between RC and LDL-C on MASLD risk: clinical cut-off points, differences of >10 percentile points and residuals. Results The median age was 62.0 years, and 48.3% had MASLD. RC was more closely associated with MASLD than LDL-C. Furthermore, discordantly high RC was associated with higher MASLD risk than discordantly high LDL-C, regardless of which method of discordance analysis is used. For example, for the residual approach, in a regression model including LDL-C and RC residual, the latter, representing the portion of RC not explained by LDL-C, was more associated with MASLD risk than LDL-C (OR=1.26, 95% CI 1.22 to 1.30 for RC residual and OR=1.04, 95% CI 1.01 to 1.07 for LDL-C); in a regression model including RC and LDL-C residual, the latter representing the portion of LDL-C not explained by RC, RC was more associated with MASLD risk than LDL-C residual (OR=1.24, 95% CI 1.20 to 1.29 for RC and OR=1.09, 95% CI 1.06 to 1.12 for LDL-C residual). Conclusions Discordantly high RC was associated with higher MASLD risk than discordantly high LDL-C. Our findings suggest that RC may serve as a potential target for prevention and intervention for MASLD.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) conducted a cross-sectional in Type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease (n=26,302). Discordantly high remnant cholesterol vs. Discordantly high LDL-C was evaluated on Metabolic dysfunction-associated steatotic liver disease (MASLD) risk (OR 1.26, 95% CI 1.22 to 1.30). Discordantly high remnant cholesterol was associated with a higher risk of metabolic dysfunction-associated steatotic liver disease than discordantly high LDL-C (OR 1.26; 95% CI 1.22-1.30).
Synapse has enriched 10 related papers. Consider them for comparative context: